CD274 and breast carcinoma: According to the systematic review from Stovgaard et al.42, PD-L1 expression in breast carcinomas variated between 0 to 83% in all different intrinsic subtypes, and most studies included in the review presented values around 50%, a figure similar to that evidenced in the present study (59%).